Skip to main content
. Author manuscript; available in PMC: 2009 Sep 10.
Published in final edited form as: J Alzheimers Dis. 2009 Feb;16(2):421–431. doi: 10.3233/JAD-2009-0980

Fig. 2. Capture of disease-associated PrP by P1 and P2.

Fig. 2

A. P1 and P2, biotinylated and coupled to streptavidin magnetic beads, were used to capture PrP from the brain homogenates of CJD patients, as well as unaffected controls (Non-CJD). Beads with no conjugated peptide, but blocked with 0.1 % BSA, were used as a negative control (None). An unrelated peptide was biotinylated and conjugated to streptavidin magnetic beads, as a second negative control (Unrelated).